(Q57664843)
Statements
Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer (English)
0 references
1 April 2006
0 references
118
0 references
1831-1835
0 references
7
0 references